USFDA issues import alert for Ranbaxy Mohali facilities

Mint 2018-02-16

Views 4

In a major blow to Ranbaxy Laboratories, USFDA has imposed a ban against its Mohali facilities. This ban is likely to impact Ranbaxy's export plans. Mint's CH Unnikrishnan has more on this
Show more

Share This Video


Download

  
Report form
RELATED VIDEOS
FDA charges data integrity issues in Wockhardt factories
play
03:33

FDA charges data integrity issues in Wockhardt factories
SpiceJet to take tough decisions on strategic operations issues soon
play
01:42

SpiceJet to take tough decisions on strategic operations issues soon
Coca Cola president on health issues
play
03:42

Coca Cola president on health issues
US issues new visa criteria for 6 Muslim nations
play
03:01

US issues new visa criteria for 6 Muslim nations
RBI issues 10 small bank licences
play
01:53

RBI issues 10 small bank licences
SpiceJet approves stake sale to Ajay Singh; issues preference shares to Marans
play
01:30

SpiceJet approves stake sale to Ajay Singh; issues preference shares to Marans
Raghuram Rajan calls for new global pact to deal with monetary policy issues
play
00:57

Raghuram Rajan calls for new global pact to deal with monetary policy issues
Money Minutes | Two tax free bond issues hit the market
play
04:01

Money Minutes | Two tax free bond issues hit the market
Ten Bollywood films on political issues
play
03:25

Ten Bollywood films on political issues
Kashmir crisis meet: Key issues discussed
play
00:44

Kashmir crisis meet: Key issues discussed
Indian high yield bond issues surge to record highs
play
01:08

Indian high yield bond issues surge to record highs
Warrant issued for Vijay Mallya’s arrest in money laundering case
play
01:12

Warrant issued for Vijay Mallya’s arrest in money laundering case